Paladin has provided funding support to Eastland Medical Systems Limited for Eastland?s development of ArTiMist?, a sub-lingual (under the tongue) spray for the treatment of severe and complicated malaria in children. After completion of a successful clinical trial involving 30 children that confirmed the effectiveness of the malaria treatment in young children, Eastland has moved on to a 150-patient multi centre superiority study in Africa. Trials have been progressing well with an initial 50 patients treated in Rwanda. The additional 100 patients are being recruited for treatment in the Burkina Faso, Ghana and Tanzanian arms of the trial.
EMS Price at posting:
2.1¢ Sentiment: Buy Disclosure: Held
